OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Home Antibody All anti-SUFU antibodies

Anti-SUFU Antibody EPR1206Y


Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
  • Rabbit Monoclonal Antibody against SUFU (Clone EPR1206Y)
  • Free Sample of Positive Control: HEK293T cell transient overexpression lysate (LC402511) , 20ug Explanation
100ul $325 3-7 Days
Add to Shopping Cart

OriGene Data

ImmunogenA synthetic peptide corresponding to peptides on the N-terminus o f human SuFu was used as an immunogen.
Clone NameEPR1206Y IsotypeIgG
Species ReactivityHuman (Does not react with: Mouse, Rat) ConcentrationLot dependent; please refer to CoA along with shipment
Guaranteed Application *WB, IHC, FC Suggested DilutionsWB: 1:1000 - 1:2000; IP: 1:50; IHC-P: 1:100; FC: 1:100
BufferPBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%
Purification Tissue culture supernatant
Note Is unsuitable for ICC/IF.

Reference Data

Target NameHomo sapiens suppressor of fused homolog (Drosophila) (SUFU), transcript variant 1
Alternative NamePRO1280; SUFUH; SUFUXL
Database LinkNP_057253
Entrez Gene 51684 Human
FunctionThe Hedgehog (Hh) signaling pathway has conserved roles in development of species ranging from Drosophila to humans. Human supressor of fused Su(Fu) acts as a negative regulator in the hedgehog signaling (SHH) pathway by down-regulating GLI1-mediated transactivation of target genes (1). Su(fu) was found to repress activity of the zinc-finger transcription factor Gli, which mediates Hedgehog signaling in vertebrates, and to physically interact with Gli, Gli2 and Gli3 (2). The sonic hedgehog signaling pathway directs the embryonic development of diverse organisms and is disrupted in a variety of malignancies. Several of mutations encode truncated proteins that are unable to export the GLI transcription factor from nucleus to cytoplasm, resulting in the activation of SHH signaling. SUFU is a newly identified tumor-suppressor gene that predisposes individuals to medulloblastoma by modulating the SHH signaling pathway through a newly identified mechanism (3).
Related PathwayTranscription FactorsDruggable Genome Hedgehog signaling pathwayPathways in cancerBasal cell carcinoma

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Western blot - Suppressor of Fused antibody [EPR1206Y]; All lanes : Anti-Suppressor of Fused antibody [EPR1206Y] at 1/2000 dilution.Lane 1 : Hela cell lysate.Lane 2 : Human kidney cell lysate.Lysates/proteins at 10 ug per lane.Secondary.HRP labelled goat anti-rabbit at 1/2000 dilution.Predicted band size : 54 kDa.Observed band size : 54 kDa.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Suppressor of Fused antibody [EPR1206Y]; TA301261 at 1/100 dilution staining Suppressor of Fused in human testis tissue, using a HRP/AP polymerized secondary antibody.
Flow Cytometry - Anti-Suppressor of Fused antibody [EPR1206Y]; Overlay histogram showing HEK293 cells stained with TA301261 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody for 30 min at 22°C. The secondary antibody used was DyLight 488 goat anti-rabbit IgG (H+L) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1ug/1x10^6 cells) used under the same conditions. Acquisition of >5,000 events was performed.


Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title